Adar Poonawala
- All
- News
- Videos
-
Exclusive: "Telling China To Take Our Booster," Adar Poonawalla Tells NDTV
The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.
-
China Covid Surges, Vaccine Maker Adar Poonawalla says "Needn't Panic"
Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
Amid Monkeypox Worry, What Adar Poonawalla Said On Making Vaccine
Amid worries over four monkeypox cases in India, vaccine-maker Adar Poonawalla said today that he is exploring the possibility of importing smallpox vaccine in bulk "in an emergency situation".
-
Serum Institute CEO Adar Poonawalla Asks Elon Musk to Invest in Making Tesla Cars in India
Serum Institute of India (SII) CEO Adar Poonawalla tagged Elon Musk in a tweet and asked him to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made.
-
Covishield Booster At Rs 600 Plus Tax: Adar Poonawalla To NDTV
Mr Poonawala told NDTV that Covishield will cost Rs 600 plus taxes (same as before) and Covovax, once approved as a booster, will be available for Rs.900 plus taxes.
-
Watch: In Adar Poonawalla's Tennis Video, A Request For Novak Djokovic
In a recent interview with the BBC, the tennis star had said that he is willing to not take part in tournaments if he is asked to be vaccinated.
-
What Adar Poonawalla Said On Father Getting Padma Bhushan
Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year.
-
Developing More Effective Booster Shots Against Omicron: Adar Poonawala
Serum Institute of India is working to develop a vaccine booster shot more effective against the Omicron strain, its Chief Executive Officer Adar Poonawalla said today.
-
Adar Poonawalla Says Vaccine For Children In 6 Months
The world's largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm's chief executive said on Tuesday.
-
Omicron-Specific Booster Shot Possible, Says Adar Poonawalla To NDTV: Highlights
As new Covid strain 'Omicron' raises alarm across the globe, Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, in an exclusive interview to NDTV said that Omicron-specific booster shots are possibl
-
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
-
Serum Institute Distances Itself From Officials Remarks On Vaccination
Serum Institute of India clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company,
-
Serum Institute Plans To Begin Vaccine Production Outside India: Report
The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.
-
On Slow US Response To India's Covid Crisis, China's Strategic Digs
With the US dragging its feet in offering India help to combat the world's worst virus crisis, China is moving to drive a wedge between the democratic security partners.
-
Exclusive: "Telling China To Take Our Booster," Adar Poonawalla Tells NDTV
The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.
-
China Covid Surges, Vaccine Maker Adar Poonawalla says "Needn't Panic"
Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
Amid Monkeypox Worry, What Adar Poonawalla Said On Making Vaccine
Amid worries over four monkeypox cases in India, vaccine-maker Adar Poonawalla said today that he is exploring the possibility of importing smallpox vaccine in bulk "in an emergency situation".
-
Serum Institute CEO Adar Poonawalla Asks Elon Musk to Invest in Making Tesla Cars in India
Serum Institute of India (SII) CEO Adar Poonawalla tagged Elon Musk in a tweet and asked him to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made.
-
Covishield Booster At Rs 600 Plus Tax: Adar Poonawalla To NDTV
Mr Poonawala told NDTV that Covishield will cost Rs 600 plus taxes (same as before) and Covovax, once approved as a booster, will be available for Rs.900 plus taxes.
-
Watch: In Adar Poonawalla's Tennis Video, A Request For Novak Djokovic
In a recent interview with the BBC, the tennis star had said that he is willing to not take part in tournaments if he is asked to be vaccinated.
-
What Adar Poonawalla Said On Father Getting Padma Bhushan
Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year.
-
Developing More Effective Booster Shots Against Omicron: Adar Poonawala
Serum Institute of India is working to develop a vaccine booster shot more effective against the Omicron strain, its Chief Executive Officer Adar Poonawalla said today.
-
Adar Poonawalla Says Vaccine For Children In 6 Months
The world's largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm's chief executive said on Tuesday.
-
Omicron-Specific Booster Shot Possible, Says Adar Poonawalla To NDTV: Highlights
As new Covid strain 'Omicron' raises alarm across the globe, Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, in an exclusive interview to NDTV said that Omicron-specific booster shots are possibl
-
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
-
Serum Institute Distances Itself From Officials Remarks On Vaccination
Serum Institute of India clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company,
-
Serum Institute Plans To Begin Vaccine Production Outside India: Report
The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.
-
On Slow US Response To India's Covid Crisis, China's Strategic Digs
With the US dragging its feet in offering India help to combat the world's worst virus crisis, China is moving to drive a wedge between the democratic security partners.
